EichorEICHOR
Study identifier: NCT05701800 Synced from ClinicalTrials.gov · August 06, 2026
● Study status: Terminated

A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1468 in Healthy Adults ≥50 Years of Age

Condition: Herpes Zoster  ·  Sponsor: ModernaTX, Inc.

PhasePhase 1
Planned participants659
Who can joinAll sexes, 50 Years to no upper limit
Healthy volunteersYes

About this study

The purpose of this first-in-human study is to evaluate the safety and immunogenicity of mRNA-1468.

This description comes directly from the study's public registry record.

Talk to the study team

No contact information is available for this study as per the public registry record.

Always discuss trial participation with your own doctor first.

Locations (20)

Velocity Clinical Research - WestlakeLos Angeles, California, United States
Tekton Research, Inc - Longmont CenterLongmont, Colorado, United States
Meridien ResearchLakeland, Florida, United States
Clinical Trials of Florida, LLCMiami, Florida, United States
Floridian Clinical ResearchMiami Lakes, Florida, United States
Florida Pulmonary Research Institute, LLCWinter Park, Florida, United States
Centricity ResearchColumbus, Georgia, United States
Great LakesChicago, Illinois, United States
DM Clinical Research- River ForestRiver Forest, Illinois, United States
Meridian Clinical Research - Dakota DunesSioux City, Iowa, United States
Johnson County Clin-Trials (JCCT)Lenexa, Kansas, United States
NOLA Research WorksNew Orleans, Louisiana, United States

+ 8 more locations — full list on the registry record.

Follow this study

Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.

We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →